Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
27.11
-3.05 (-10.11%)
At close: Apr 24, 2026, 4:00 PM EDT
27.20
+0.09 (0.33%)
After-hours: Apr 24, 2026, 7:56 PM EDT

Beam Therapeutics Revenue

In the year 2025, Beam Therapeutics had annual revenue of $139.74M with 120.01% growth. Beam Therapeutics had revenue of $114.11M in the quarter ending December 31, 2025, with 279.52% growth.

Revenue (ttm)
$139.74M
Revenue Growth
+120.01%
P/S Ratio
19.44
Revenue / Employee
$273,470
Employees
511
Market Cap
2.72B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025139.74M76.23M120.01%
Dec 31, 202463.52M-314.19M-83.18%
Dec 31, 2023377.71M316.79M520.01%
Dec 31, 202260.92M9.08M17.51%
Dec 31, 202151.84M51.82M215,916.67%
Dec 31, 202024.00K6.00K33.33%
Dec 31, 201918.00K--
Dec 31, 2018---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition